tirzepatide gastroparesis case report Should new or worsening constipation or symptoms in a patient taking low‑dose Zepbound (tirzepatide) be considered reasons to stop the medication? Gastrointestinal adverse events and weight

gastrointestinal effects are more relevant with metformin-containing Janumet

At Medilink Healthcare, our commitment has always been to make trusted, science-backed treatments accessible to healthcare professionals and patients across India

"It'll have the muscle-boosting, muscle-building effects, but it will promote fluid retention, it will promote osteoarthritis, inflammation, deranged glucose metabolism and increased diabetes risk if she's a susceptible person," she said

Mancuso R, Del Valle J, Morell M, Palls M, Osta R, Navarro X

[1] [2] When intestinal transit accelerates during diarrheal episodes, the normal reabsorption of intestinal secretions decreases, and protective mucus may become more prominent